DOI QR코드

DOI QR Code

Thymocyte Differentiation is Regulated by a Change in Estradiol Levels during the Estrous Cycle in Mouse

  • Lee, Hyojin (Department of Bioenvironmental Technology, College of Natural Sciences, Seoul Women's University) ;
  • Kim, Heejung (Department of Bioenvironmental Technology, College of Natural Sciences, Seoul Women's University) ;
  • Chung, Yiwa (Department of Bioenvironmental Technology, College of Natural Sciences, Seoul Women's University) ;
  • Kim, Jinhee (Department of Bioenvironmental Technology, College of Natural Sciences, Seoul Women's University) ;
  • Yang, Hyunwon (Department of Bioenvironmental Technology, College of Natural Sciences, Seoul Women's University)
  • Received : 2013.11.30
  • Accepted : 2013.12.22
  • Published : 2013.12.31

Abstract

Recent study showed that T cells in the immune organs and peripheral blood are influenced by estradiol, leading to a dysfunction of the immune system. However, little is known about the thymic-gonadal relationship during the estrous cycle in mouse. Therefore, the purpose of this study was to elucidate the mechanism by which a change in estradiol levels during the estrous cycle regulates the development of T cells in the mouse thymus. Six-week-old ICR mice were used and divided into four groups, including diestrous, proestrous, estrous, and metestrous. We first confirmed that ER-${\alpha}$ and - ${\beta}$ estrogen receptors were expressed in thymic epithelial cells, showing that their expression was not different during the estrous cycle. There was also no significant difference in thymic weight and total number of thymocytes during the estrous cycle. To determine the degree of thymocyte differentiation during the estrous cycle, we analyzed thymocytes by flow cytometry. As a result, the percentage of CD4+CD8+ double-positive (DP) T cells was significantly decreased in the proestrous phase compared to the diestrous phase. However, CD4+CD8- or CD4-CD8+ (SP) T cells were significantly increased in the proestrous phase compared to the diestrous phase. In addition, the percentage of CD44+CD25- (DN1) T cells was significantly decreased in the estrous phase compared to other phases, whereas the percentages of CD44+CD25+ (DN2), CD44-CD25+ (DN3), and CD44-CD25- (DN4) were not changed during the estrous cycle. These results indicate that the development of thymocytes may arrest in the DP to SP transition stage in the proestrous phase displaying the highest serum level of estradiol. This study suggests that a change in estradiol levels during the estrous cycle may be involved in the regulation of thymocyte differentiation in the mouse thymus.

Keywords

References

  1. Anderson G, Jenkinson EJ (2001) Lymphostromal interactions in thymic development and function. Nat Rev Immunol 1:31-40. https://doi.org/10.1038/35095500
  2. Anderson G, Jenkinson WE, Jones T, Parnell SM, Kinsella FA, White AJ, Pongracz JE, Rossi SW, Jenkinson EJ (2006) Establishment and functioning of intrathymic microenvironments. Immunol Rev 209:10-27. https://doi.org/10.1111/j.0105-2896.2006.00347.x
  3. Boyd RL, Tucek CL, Godfrey DI, Izon DJ, Wilson TJ, Davidson NJ, Bean AG, Ladyman HM, Ritter MA, Hugo P (1993) The thymic microenvironment. Immunol Today 14:445-459. https://doi.org/10.1016/0167-5699(93)90248-J
  4. Brunelli R, Frasca D, Baschieri S, Spano M, Fattorossi A, Mosiello LF, D'Amelio R, Zichella L, Doria G (1992) Changes in thymocyte subsets induced by estradiol administration or pregnancy. Ann N Y Acad Sci 650: 109-114. https://doi.org/10.1111/j.1749-6632.1992.tb49105.x
  5. Chidgey A, Dudakov J, Seach N, Boyd R (2007) Impact of niche aging on thymic regeneration and immune reconstitution. Semin Immunol 19:331-340. https://doi.org/10.1016/j.smim.2007.10.006
  6. Clarke AG, Kendall MD (1994) The thymus in pregnancy: the interplay of neural, endocrine and immune influences. Immunol Today 15:545-551. https://doi.org/10.1016/0167-5699(94)90212-7
  7. Couse JF, Korach KS (1999) Estrogen receptor null mice: what have we learned and where will they lead us? Endocr Rev 20:358-417. https://doi.org/10.1210/edrv.20.3.0370
  8. Dardenne M, Savino W (1996) Interdependence of the endocrine and immune systems. Adv Neuroimmunol 6:297-307. https://doi.org/10.1016/S0960-5428(97)00030-7
  9. Di Santo JP, Rodewald HR (1998) In vivo roles of receptor tyrosine kinases and cytokine receptors in early thymocyte development. Curr Opin Immunol 10:196-207. https://doi.org/10.1016/S0952-7915(98)80249-5
  10. Do Y, Ryu S, Nagarkatti M, Nagarkatti PS (2002) Role of death receptor pathway in estradiol-induced T-cell apoptosis in vivo. Toxicol Sci 70:63-72. https://doi.org/10.1093/toxsci/70.1.63
  11. Erlandsson MC, Ohlsson C, Gustafsson JA, Carlsten H (2001) Role of oestrogen receptors alpha and beta in immune organ development and in oestrogen-mediated effects on thymus. Immunology 103:17-25. https://doi.org/10.1046/j.1365-2567.2001.01212.x
  12. Fabris N, Mocchegiani E, Provinciali M (1997) Plasticity of neuro-endocrine-thymus interactions during aging--a minireview. Cell Mol Biol (Noisy-le-grand) 43:529-541.
  13. Holladay SD, Blaylock BL, Comment CE, Heindel JJ, Fox WM, Korach KS, Luster MI (1993) Selective prothymocyte targeting by prenatal diethylstilbesterol exposure. Cell Immunol 152:131-142. https://doi.org/10.1006/cimm.1993.1273
  14. Holub M, Rossmann P, Tlaskalova H, Vidmarova H (1975) Thymus rudiment of the athymic nude mouse. Nature 256:491-493. https://doi.org/10.1038/256491a0
  15. Jenkinson WE, Bacon A, White AJ, Anderson G, Jenkinson EJ (2008) An epithelial progenitor pool regulates thymus growth. J Immunol 181:6101-6108. https://doi.org/10.4049/jimmunol.181.9.6101
  16. Jenkinson WE, Rossi SW, Parnell SM, Jenkinson EJ, Anderson G (2007) PDGFRalpha-expressing mesenchyme regulates thymus growth and the availability of intrathymic niches. Blood 109:954-960.
  17. Kawashima I, Seiki K, Sakabe K, Ihara S, Akatsuka A, Katsumata Y (1992) Localization of estrogen receptors and estrogen receptor-mRNA in female mouse thymus. Thymus 20:115-121.
  18. Kuiper GG, Carlsson B, Grandien K, Enmark E, Haggblad J, Nilsson S, Gustafsson JA (1997) Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 138:863-870.
  19. Luster MI, Hayes HT, Korach K, Tucker AN, Dean JH, Greenlee WF, Boorman GA (1984) Estrogen immunosuppression is regulated through estrogenic responses in the thymus. J Immunol 133:110-116.
  20. Malek TR, Porter BO, He YW (1999) Multiple gamma c-dependent cytokines regulate T-cell development. Immunol Today 20:71-76. https://doi.org/10.1016/S0167-5699(98)01391-7
  21. Mocchegiani E, Santarelli L, Costarelli L, Cipriano C, Muti E, Giacconi R, Malavolta M (2006) Plasticity of neuroendocrine-thymus interactions during ontogeny and ageing: role of zinc and arginine. Ageing Res Rev 5:281-309. https://doi.org/10.1016/j.arr.2006.06.001
  22. Mor G, Munoz A, Redlinger R Jr, Silva I, Song J, Lim C, Kohen F (2001) The role of the Fas/Fas ligand system in estrogen-induced thymic alteration. Am J Reprod Immunol 46:298-307. https://doi.org/10.1034/j.1600-0897.2001.d01-16.x
  23. Okasha SA, Ryu S, Do Y, McKallip RJ, Nagarkatti M, Nagarkatti PS (2001) Evidence for estradiol-induced apoptosis and dysregulated T cell maturation in the thymus. Toxicology 163:49-62. https://doi.org/10.1016/S0300-483X(01)00374-2
  24. Petrie HT (2003) Cell migration and the control of postnatal T-cell lymphopoiesis in the thymus. Nat Rev Immunol 3:859-866. https://doi.org/10.1038/nri1223
  25. Revest JM, Suniara RK, Kerr K, Owen JJ, Dickson C (2001) Development of the thymus requires signaling through the fibroblast growth factor receptor R2-IIIb. J Immunol 167:1954-1961. https://doi.org/10.4049/jimmunol.167.4.1954
  26. Rijhsinghani AG, Thompson K, Bhatia SK, Waldschmidt TJ (1996) Estrogen blocks early T cell development in the thymus. Am J Reprod Immunol 36:269-277. https://doi.org/10.1111/j.1600-0897.1996.tb00176.x
  27. Ritter MA, Boyd RL(1993) Development in the thymus: it takes two to tango. Immunol Today 14:462-469. https://doi.org/10.1016/0167-5699(93)90250-O
  28. Screpanti I, Morrone S, Meco D, Santoni A, Gulino A, Paolini R, Crisanti A, Mathieson BJ, Frati L (1989) Steroid sensitivity of thymocyte subpopulations during intrathymic differentiation. Effects of 17 beta-estradiol and dexamethasone on subsets expressing T cell antigen receptor or IL-2 receptor. J Immunol 142:3378-3383.
  29. Silverstone AE, Frazier DE Jr, Fiore NC, Soults JA, Gasiewicz TA (1994) Dexamethasone, beta-estradiol, and 2,3,7,8-tetrachlorodibenzo-p-dioxin elicit thymic atrophy through different cellular targets. Toxicol Appl Pharmacol 126:248-259. https://doi.org/10.1006/taap.1994.1114
  30. Staples JE, Gasiewicz TA, Fiore NC, Lubahn DB, Korach KS, Silverstone AE (1999) Estrogen receptor alpha is necessary in thymic development and estradiol-induced thymic alterations. J Immunol 163:4168-4174.
  31. Takahama Y (2006) Journey through the thymus: stromal guides for T-cell development and selection. Nat Rev Immunol 6:127-135. https://doi.org/10.1038/nri1781
  32. Thyagarajan S, Felten DL (2002) Modulation of neuroendocrine--immune signaling by L-deprenyl and Ldesmethyldeprenyl in aging and mammary cancer. Mech Ageing Dev 123:1065-1079. https://doi.org/10.1016/S0047-6374(01)00390-6
  33. Wang C, Dehghani B, Magrisso IJ, Rick EA, Bonhomme E, Cody DB, Elenich LA, Subramanian S, Murphy SJ, Kelly MJ, Rosenbaum JS, Vandenbark AA, Offner H (2008) GPR30 contributes to estrogen-induced thymic atrophy. Mol Endocrinol 22:636-648. https://doi.org/10.1210/me.2007-0359
  34. Yao G, Hou Y (2004) Thymic atrophy via estrogen-induced apoptosis is related to Fas/FasL pathway. Int Immunopharmacol 4:213-221. https://doi.org/10.1016/j.intimp.2003.12.005
  35. Yellayi S, Naaz A, Szewczykowski MA, Sato T, Woods JA, Chang J, Segre M, Allred CD, Helferich WG, Cooke PS (2002) The phytoestrogen genistein induces thymic and immune changes: a human health concern? Proc Natl Acad Sci U S A 99:7616-7621. https://doi.org/10.1073/pnas.102650199